1. Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial. Issue 10 (October 2018) Authors: Ferguson, Gary T; Rabe, Klaus F; Martinez, Fernando J; Fabbri, Leonardo M; Wang, Chen; Ichinose, Masakazu; Bourne, Eric; Ballal, Shaila; Darken, Patrick; DeAngelis, Kiernan; Aurivillius, Magnus; Dorinsky, Paul; Reisner, Colin Journal: Lancet Issue: Volume 6:Issue 10(2018) Page Start: 747 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial. Issue 10056 (29th October 2016) Authors: FitzGerald, J Mark; Bleecker, Eugene R; Nair, Parameswaran; Korn, Stephanie; Ohta, Ken; Lommatzsch, Marek; Ferguson, Gary T; Busse, William W; Barker, Peter; Sproule, Stephanie; Gilmartin, Geoffrey; Werkström, Viktoria; Aurivillius, Magnus; Goldman, Mitchell Journal: Lancet Issue: Volume 388:Issue 10056(2016) Page Start: 2128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Number needed to treat in COPD: exacerbations versus pneumonias. Issue 9 (15th March 2013) Authors: Keene, Oliver N; Anzueto, Antonio; Ferguson, Gary T; Calverley, Peter M A Journal: Thorax Issue: Volume 68:Issue 9(2013) Page Start: 882 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cardiovascular events in patients with COPD: TORCH Study results. Issue 8 (4th August 2010) Authors: Calverley, Peter M A; Anderson, Julie A; Celli, Bartolome; Ferguson, Gary T; Jenkins, Christine; Jones, Paul W; Crim, Courtney; Willits, Lisa R; Yates, Julie C; Vestbo, Jørgen Journal: Thorax Issue: Volume 65:Issue 8(2010) Page Start: 719 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial. Issue 1 (January 2019) Authors: Busse, William W; Bleecker, Eugene R; FitzGerald, J Mark; Ferguson, Gary T; Barker, Peter; Sproule, Stephanie; Olsson, Richard F; Martin, Ubaldo J; Goldman, Mitchell Journal: Lancet Issue: Volume 7:Issue 1(2019) Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗